Miroslav Gasparek, CEO and co-founder of Sensible Biotechnologies, started his journey with a strong desire to help people through innovation. Originally from Slovakia, Miroslav set out to make a real impact in healthcare by advancing RNA technology. As a first-time scientific founder, he has transitioned from the research lab to leading a groundbreaking biotech company in Cambridge. Sensible Bio is at the forefront of producing high-quality RNA for transformative applications like mRNA vaccines and gene therapies. In this discussion, Miroslav shares the inspiring vision that drives Sensible Bio, the challenges of building a company around cutting-edge technology, and how innovations in mRNA could reshape the future of medicine.